1 Bold Prediction for NuScale Power in 2026

NuScale Power, the only U.S. firm with an NRC‑approved SMR design, still has not signed its first paying customer after the 2023 cancellation of the Carbon Free Power Project (costs nearly doubled from ~$5.3B to $9.4B and prompted a ~20% stock drop). Management had forecast two to three customers by end‑2025 but none have materialized; however, engagements with Romania's RoPower (potential six reactors) and the Tennessee Valley Authority (up to 6 GW) make a 2026 first customer — likely state‑backed or institutionally supported — a realistic outcome, which would validate a commercial deployment pathway though not immediately restore profitability.

Analysis

Market structure: NuScale’s NRC-approved design creates a technical moat but no commercial pricing power until a paying customer appears; winners in the near term are uranium miners/ETFs (e.g., URA) and component suppliers (e.g., BWXT) that can pick up manufacturing orders, while small-cap clean-energy developers and NuScale (SMR) equity are losers on program risk. Competitive dynamics favor incumbents with balance-sheet scale for multi‑GW projects; a single state-backed contract in 2026 would validate SMRs but still leave fragmented procurement and upward pressure on EPC pricing.

Risk assessment: Tail risks include a regulatory reversal, another multi‑billion project cancellation, or sovereign non-payment—each could wipe out >50% of SMR equity value; conversely, a 2026 state-backed contract would likely lift shares >100% (binary). Immediate (days) risk is headline-driven volatility; short-term (3–12 months) hinges on RoPower/TVA announcements and cash runway; long-term (2–5 years) depends on financing models and supply‑chain capacity (large forgings, fuel supply).

Trade implications: Tactical books should size exposure small and option-protected. Preferred direct plays: tactical short SMR (1–2% NAV) via 6–12 month put-spread and a 2–4% overweight in URA (12–36 month horizon) to capture structural uranium upside if SMR commercialization accelerates. Pair trade: long BWXT (1–2%) vs short SMR (1–2%) to express industrial capture of SMR build activity while avoiding single-name binary risk.

Contrarian angles: Consensus understates the value of regulatory first-mover status as a barrier for new entrants—if NuScale secures a state-backed offtake in 2026, the stock could re-rate materially; the market may be over-penalizing SMR for CFPP’s cost overrun without pricing in possible sovereign underwriting. Historical parallel: early utility-scale wind and solar saw multi-year commercialization lags followed by concentrated winner-take-most gains once bankable projects proved economics.

Key Decisions for Investors

• Establish a tactical short position in SMR sized 1–2% of NAV via a 6–12 month put spread (buy 1x ~25% OTM put, sell 1x ~50% OTM put) to cap premium; cover if NuScale signs a binding customer contract or stock rallies >40% from current levels.
• Initiate a 2–4% overweight in Global X Uranium ETF (URA) with a 12–36 month horizon; add another 1–2% if RoPower or TVA announce binding offtake/financing within 6–12 months or if uranium spot rises >15% on contract news.
• Enter a pair trade: long BWXT (1–2% NAV) vs short SMR (1–2% NAV) to capture industrial upside from SMR builds while hedging project/counterparty risk; trim longs if BWXT outperforms by >30% or if SMR signs a confirmed multi-unit contract.
• Reallocate 3–5% from small-cap clean-energy growth names into regulated utilities and uranium exposure over the next 30 days (incremental weekly executions) to reduce binary project risk and capture structural fuel/utility demand if SMRs scale.